Discontinuation report HEPTOVIR
| Report ID | 160503 |
| Drug Identification Number | 02239194 |
| Brand name | HEPTOVIR |
| Common or Proper name | lamivudine oral solution |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LAMIVUDINE |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | All pack sizes / Tous les formats |
| ATC code | J05AF |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2022-07-13 |
| Remaining supply date | 2023-02-28 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-07-22 | French | Compare |
| v3 | 2022-07-22 | English | Compare |
| v2 | 2022-05-13 | French | Compare |
| v1 | 2022-05-13 | English | Compare |
Showing 1 to 4 of 4